Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,815 across all filing types
Latest filing 2026-04-01 Major Shareholding Noti…
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
Major Shareholder Announcement
Major Shareholding Notification Classification · 1% confidence The document is a standardized notification form detailing a change in major shareholdings, including the identity of the reporting shareholder, the exact date the 5% voting threshold was crossed, and before/after voting rights percentages in accordance with sections of the Capital Markets Act. This aligns precisely with a Major Shareholding Notification. There is no indication of financial results, board changes, earnings, or other report types but solely a threshold crossing disclosure under regulatory rules. Therefore, it is classified as MRQ: Major Shareholding Notification.
2026-04-01 English
Major Shareholder Announcement
Major Shareholding Notification Classification · 1% confidence The document is a company announcement notifying that Orbis Investment Management Limited has acquired and now controls 5.01% of Genmab’s share capital, referencing Section 30 of the Danish Capital Markets Act. This is clearly a notification of changes in a significant shareholding threshold being crossed. According to the filing definitions, this fits “Major Shareholding Notification” (Code: MRQ).
2026-04-01 English
Major Shareholder Announcement
Major Shareholding Notification Classification · 1% confidence The document is a company announcement under Section 30 of the Danish Capital Markets Act regarding Orbis Investment Management Limited’s shareholding crossing the 5% threshold (3,221,620 shares, 5.01% of voting rights). This is clearly a notification of a change in significant share ownership levels, matching the definition of Major Shareholding Notification (Code: MRQ).
2026-04-01 English
Major Shareholder Announcement
Major Shareholding Notification Classification · 1% confidence The document is a standard regulatory form notifying a change in a major shareholding (crossing the 5% voting rights threshold) under the Capital Markets Act. It details the date of crossing, resulting and previous voting rights/share capital percentages, instrument breakdown, and chains of controlled undertakings. This matches the definition of a Major Shareholding Notification (Code: MRQ).
2026-03-30 English
Major Shareholder Announcement
Major Shareholding Notification Classification · 1% confidence The document is a company announcement titled “Major Shareholder Announcement” under Section 30 of the Danish Capital Markets Act, disclosing that Orbis Investment Management has crossed the 4.99% voting rights threshold. This clearly matches a Major Shareholding Notification.
2026-03-30 English
Major Shareholder Announcement
Major Shareholding Notification Classification · 1% confidence The document is an official announcement under Section 30 of the Danish Capital Markets Act stating that a particular investor (Orbis Investment Management Limited) has reached a 4.99% holding threshold in Genmab A/S. This is a major shareholding notification rather than a general regulatory announcement or other report type. Therefore, it best fits the “Major Shareholding Notification” category (Code: MRQ).
2026-03-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.